• SENSEX 78,154.25
    -388.19 (--0.49%)
  • BANKNIFTY 57,686.95
    -59.50 (--0.10%)
  • Bharti Airtel
    1,905.00 1,745.00(%)
  • ICICI Bank
    1,412.30 1,187.55(%)
  • HDFC Bank
    726.50 726.75(%)
  • C P C L
    1,449.00 1,354.00(%)
  • Gland Pharma
    2,989.25 2,679.00(%)
  • Life Insurance
    410.00 468.30(%)
  • Narayana Hrudaya
    1,860.45 2,094.30(%)
  • Cupid
    277.00 267.90(%)
  • Lumax Auto Tech.
    2,088.95 1,898.65(%)
  • Info Edg.(India)
    1,391.60 1,439.95(%)
  • Multi Comm. Exc.
    2,886.00 3,479.80(%)
  • ERIS Lifescience
    1,380.00 1,237.90(%)
  • One 97
    1,638.80 1,594.80(%)
  • Endurance Tech.
    3,020.00 3,078.95(%)
  • Aarti Pharma
    932.50 946.45(%)
  • Eternal
    318.30 368.40(%)
  • Finolex Cables
    1,225.00 1,204.15(%)
  • M & M
    3,455.65 2,896.30(%)
  • Hitachi Energy
    34,729.35 16,104.00(%)
  • Zydus Lifesci.
    1,205.00 1,181.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Laurus Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 45955.0
  • ISIN : INE947Q01028
1,854.00 10 (0.53%)
  • As on 11 Aug 2026 (EOD)

  • Today’s Low

    1,832.80

  • Today’s High

    1,870.80

  • Open

    1,845.00

  • Perv Close

    1,844.30

  • 52W Low

    810.05

  • 52W High

    1,870.80

Key Indicators

  • P/E(TTM)

    115.54

  • Mar.Cap (₹Cr.)

    100,173.89

  • Div & Yield %

    0.11

  • Book Value(₹)

    97.20

  • Debt-Equity Ratio

    0.53

  • AGM Date

    10-Aug-2026

  • EPS

    16.15

  • P/E Ratio

    115.54

Financials Ratios

  • Debt-Equity Ratio

    0.56

  • Mar.Cap (₹Cr.)

    100,173.89

  • RONW (%)

    4.13

  • ROCE (%)

    6.31

Score Board

  • Equity (₹ in Cr.)

    108.06

  • BV (₹)

    97.20

  • Sales( ₹ in Cr.)

    6,089.07

  • NP (in Cr.)

    743.65

  • NP Var(%)

    144.0

  • Div%

    100.0

  • CPS (₹)

    20.80

  • EPS (₹)

    13.80

  • Traded Value (₹ in Lakhs)

    100,822.26

  • 52 Week High

    1,870.80

  • 52 Week Low

    810.05

  • Price BSE

    1866.0

  • Price NSE

    1,854.00

  • Market Capital( in Cr.)

    100,822.26

  • P/C Ratio

    89.80

  • P/E Ratio

    135.60

  • Price Vs.BV

    13.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 6,089.07 5,216.98 4,812.39 5,773.45 4,707.04 4,768.72
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 6,089.07 5,216.98 4,812.39 5,773.45 4,707.04 4,768.72
Other Income 77.43 100.47 47.42 15.95 21.55 27.32
Stock Adjustments 236.87 13.55 102.48 -40.82 218.62 296.45
Total Income 6,403.37 5,331.00 4,962.29 5,748.58 4,947.21 5,092.49
EXPENDITURE :            
Raw Materials 2,797.49 2,476.74 2,507.87 2,671.65 2,427.18 2,471.58
Power and Fuel Cost 330.61 289.49 309.67 301.10 188.52 149.69
Employee Cost 683.52 570.78 531.93 477.88 417.57 364.83
Other Manufacturing Expenses 585.95 482.35 491.94 431.99 326.34 298.12
Selling and Administration Expenses 393.76 393.12 293.96 323.95 265.52 260.60
Miscellaneous Expenses 96.35 73.72 29.62 44.30 15.33 10.48
Employee Benefit Expenses 683.52 570.78 531.93 477.88 417.57 364.83
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4,887.68 4,286.20 4,164.99 4,250.87 3,640.46 3,555.30
Operating Profit 1,515.69 1,044.80 797.30 1,497.71 1,306.75 1,537.19
Interest 142.96 182.20 150.82 145.70 95.86 65.92
Gross Profit 1,372.73 862.60 646.48 1,352.01 1,210.89 1,471.27
Depreciation 378.64 358.79 345.01 300.58 235.48 196.64
Profit Before Tax 994.09 503.81 301.47 1,051.43 975.41 1,274.63
Current Tax 285.12 153.84 87.94 270.78 231.42 334.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -31.51 -30.42 -10.17 20.27 -6.10 -16.46
Reported Net Profit 740.48 380.39 223.70 760.38 750.09 956.11
Extraordinary Items -3.17 75.87 -0.57 -0.14 -0.85 -0.63
Adjusted Net Profit 743.65 304.52 224.27 760.52 750.94 956.74
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 3,704.87 3,367.61 3,230.09 2,577.18 1,912.95 1,031.88
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 86.33 43.13 86.18 107.47 85.86 75.04
P & L Balance carried down 4,359.02 3,704.87 3,367.61 3,230.09 2,577.18 1,912.95
Dividend 86.33 43.13 86.18 107.47 85.86 75.04
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 60.00 40.00 100.00 100.00 100.00
Dividend Per Share(Rs) 2.00 1.20 0.80 2.00 2.00 2.00
Earnings Per Share-Unit Curr 13.72 7.05 4.15 14.12 13.96 17.82
Earnings Per Share(Adj)-Unit Curr 13.72 7.05 4.15 14.12 13.96 17.82
Book Value 97.29 84.64 78.06 75.31 63.05 50.54
Book Value(Adj)-Unit Curr 97.29 84.64 78.06 75.31 63.05 50.54

Shareholding Pattern

  • Promoter Group

    27.47%

  • Public Share Holding

    72.53%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,099,980 3.35 18,099,980 14
Partnership Firms-Indian (Promoter & Group) 130,331,740 24.12 130,331,740 2
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 148,431,720 27.47 148,431,720 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 71,214 0.01 71,214 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 151,280,078 28.00 151,280,078 405
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 12,534,538 2.32 12,534,538 17
Mutual Funds / UTI 54,846,488 10.15 54,846,488 38
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6,770,430 1.25 6,770,430 45
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 225,502,748 41.74 225,502,748 509
2] Non Institution
Bodies Corporate 42,086,799 7.79 42,086,799 1,617
Clearing Members 84,610 0.02 84,610 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,979,044 1.29 6,979,044 6,848
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,717,823 0.50 2,717,823 4,036
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 42,403,600 7.85 42,403,600 98
Individuals holding nominal share capital up to Rs. 1 lakh 68,291,359 12.64 68,291,359 278,512
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 319,055 0.06 319,055 10
Others 3,432,825 0.64 3,432,825 3
Sub Total 166,315,115 30.78 166,315,115 291,128
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 540,249,583 100.00 540,249,583 291,653

Company Background

Laurus Labs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Laurus Labs Ltd
  • BSE Code : 45955.0
  • ISIN : INE947Q01028

  • Incorporation Year

    2005

  • Registered Office

    Plot No 21 Jawaharlal Nehru
    Pharma City Parawada, Visakhapatnam,
    Andhra Pradesh-531021

  • Telephone

    91-891-3061222

  • FAX

    91-891-3061270

  • Chairman

    Ravindranath Kancherla

  • Managing Director

  • Company Secretary

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Laurus Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Laurus Labs 1,866.00 6,166.50 6,089.07 115.54 14.95
Abbott India 27,548.60 7,217.19 6,929.05 37.72 43.78
Astrazeneca Phar 8,077.30 2,304.07 2,275.58 107.68 27.86
P & G Health Ltd 5,965.30 944.52 934.17 27.75 71.75
Glaxosmi. Pharma 2,601.00 3,932.76 3,790.20 41.55 58.17
Cipla 1,460.00 20,102.60 18,979.95 38.37 13.88
Fermenta Biotec. 548.50 474.15 450.25 25.11 18.77
Amrutanjan Healt 530.10 469.50 451.82 26.47 21.89
Bliss GVS Pharma 477.25 773.53 729.81 52.33 12.51
Guj. Themis Bio. 366.45 152.47 150.80 81.98 27.21
Ambalal Sarabhai 48.34 19.52 3.94 33.80 6.77